chr11-60415456-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032597.5(MS4A14):c.488C>T(p.Ser163Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000454 in 1,609,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032597.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MS4A14 | NM_032597.5 | c.488C>T | p.Ser163Leu | missense_variant | 5/5 | ENST00000300187.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MS4A14 | ENST00000300187.11 | c.488C>T | p.Ser163Leu | missense_variant | 5/5 | 1 | NM_032597.5 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152038Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 247392Hom.: 0 AF XY: 0.0000674 AC XY: 9AN XY: 133604
GnomAD4 exome AF: 0.0000302 AC: 44AN: 1456970Hom.: 0 Cov.: 32 AF XY: 0.0000235 AC XY: 17AN XY: 724472
GnomAD4 genome AF: 0.000191 AC: 29AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The c.488C>T (p.S163L) alteration is located in exon 5 (coding exon 5) of the MS4A14 gene. This alteration results from a C to T substitution at nucleotide position 488, causing the serine (S) at amino acid position 163 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at